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Introduction
Reactive arthritis (ReA) is an acute, aseptic, inflammatory 
arthritis triggered by several types of enteric and genital 
bacterial infections. The leading bacterial triggers are 
Salmonella, Shigella, Yersinia, and Campylobacter species. 
Unlike other enteric pathogens, Clostridium difficile does not 
commonly cause ReA (1-3). We herein present a rare case of 
C. difficile infection-associated reactive arthritis (CDIAReA) in a 
10-year-old child, who developed severe diarrhea and a knee 
effusion following a course of oral antibiotic treatment.
Case Report
A 10-year-old boy with no history of trauma was admitted 
to a pediatric emergency department (PED) owing to a 3-day 
history of pain and swelling in his left knee. His parents stated 
that he had also complained of migratory pain in his ankles 
and right shoulder for 4 days. Two weeks before admission, he 
had completed a 7-day course of oral cefpodoxime for acute 
sinusitis. Five days after discontinuing the antibiotic treatment, 
he developed watery diarrhea persisting at the time of admis-
sion. In the PED, the patient was moderately ill-looking, with a 
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Öz
Clostridium difficile, çocuklarda nadir olarak bildirilmiş bir reaktif artrit 
nedenidir. Burada antibiyotik tedavisi sonrası ishal ve sol diz ekleminde 
efüzyon gelişen nadir bir C. difficile ilişkili reaktif artrit olgusu sunulmuş-
tur. Bu olgu ile antibiyotik ilişkili ishal zemininde gelişen akut ve ağrılı 
artritle başvuran çocuklarda ayırıcı tanıda C. difficile ilişkili reaktif artritin 
de düşünülmesi gerektiği vurgulanmak istenmiştir.
Anahtar Terimler: Antibiyotik ilişkili ishal, Clostridium difficile, reaktif 
artrit
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temperature of 39°C, a heart rate of 115 beats/minute, a respira-
tory rate of 22 breaths/minute, and a blood pressure of 115/80 
mmHg. His left knee was swollen, warm to touch, and extreme-
ly tender upon palpation, with limited flexion and extension, 
owing to pain (Figure 1). There were no abnormalities in his oth-
er joints, eyes, skin, and genitourinary system.
Notable laboratory results were as follows: white blood cell 
(WBC) count, 22.400/μL with 84% neutrophils; hemoglobin, 12 
g/dL; platelet count, 568.000/μL; erythrocyte sedimentation 
rate (ESR), 56 mm/h; and C-reactive protein (CRP), 18 mg/dL. 
A radiograph of the left knee showed a joint effusion without 
bony abnormalities, and subsequent magnetic resonance im-
aging revealed a large knee joint effusion (Figure 2). Joint aspi-
ration yielded 8 mL of cloudy fluid. The WBC count of the syno-
vial fluid was 1.980/mm3 with 78% neutrophils. 
The patient was hospitalized, and empiric therapy with in-
travenous cefazolin (150 mg/kg per day in 3 divided doses) was 
administered for the presumptive diagnosis of septic arthritis. 
Blood culture and synovial fluid Gram stain and culture ob-
tained at admission yielded negative results 2 days later. The 
antinuclear antibody, antistreptolysin O titer, and rheumatoid 
factor tests yielded negative results. The results of a urinalysis 
were normal, as were those of liver and kidney function tests. 
Despite antibiotic treatment, the patient’s fever and joint 
symptoms persisted, prompting a referral to our Pediatric 
Infectious Diseases Department. He continued to pass large 
amounts of watery stool (> 6 stools per day) and experienced 
lower abdominal cramping during hospitalization. Microscopic 
examination of his stool showed many leukocytes and 
erythrocytes. Stool cultures yielded negative results for 
Figure 1. Left knee swelling (white arrow) at admission.
Figure 2. Axial (a) and coronal (b) plane fat-saturated T2-weighted magnetic resonance images of the left knee showed a large 
amount of joint effusion (white arrows).
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Salmonella, Shigella, Yersinia, and Campylobacter species. On the 
fourth day of hospitalization, C. difficile toxin B was detected in 
the patient’s stool sample by an immunochromatographic assay 
(Xpect Clostridium difficile Toxin A/B test). C. difficile toxin B gene 
(tcdB) was also subsequently detected by real-time polymerase 
chain reaction assay (Xpert; Cepheid, Sunnyvale, CA).
Based on the clinical features of the illness (diarrhea imme-
diately following the antibiotic treatment and the positive stool 
test for C. difficile toxin B), we proposed a diagnosis of CDIAReA. 
Cefazolin was replaced by oral metronidazole (30 mg/kg/day in 
4 divided doses), and oral ibuprofen (30 mg/kg/day in 3 divid-
ed doses) was also administered. Within 10 days, the patient’s 
diarrhea and joint symptoms resolved, with normalization of 
the acute-phase response. The patient was discharged from the 
hospital after receiving oral metronidazole and ibuprofen for 10 
days. An ultrasound scan of his left knee showed minimal ef-
fusion at the 3-week follow-up. The patient was asymptomatic 
over a follow-up period of 24 months.
Discussion
C. difficile infection-associated reactive arthritis (CDIAReA) 
has rarely been reported in children (4-8). In a recent study, the 
annual estimated incidence of CDIAReA among children in 3 
pediatric health networks in the United States was 14/1000 (1). 
Children with CDIAReA present with pain, swelling, and limited 
movement in the joints, most commonly the knees and hips. 
The arthritis is asymmetric, migratory, and often accompanied 
by fever. Joint symptoms begin 1-2 weeks after the onset of di-
arrhea, and symptoms resolve within 1-3 weeks after treatment 
for C. difficile infection. Tell-tale signs of CDIAReA in children 
presenting with fever and severe joint pain include a history of 
migratory pain or polyarthralgia and preceding antibiotic as-
sociated diarrhea (1). Our patient’s joint symptoms appeared 1 
week after the onset of diarrhea and resolved within 10 days of 
initiating treatment for C. difficile infection. 
Differentiating between septic arthritis and ReA of the knee 
in children can be challenging given their similar presentations: 
a non-traumatic, acutely painful knee accompanied by fever, 
joint effusion, and abnormalities in the blood and joint fluid 
(1,2). The initial clinical presentation in  our case, which included 
fever, painful knee swelling, and elevated levels of inflammato-
ry markers (CRP and the ESR), was suggestive of septic arthritis, 
which is mainly caused by Staphylococcus aureus in children. 
It is essential to distinguish between septic arthritis and 
ReA in children since their treatments and complications differ. 
Septic arthritis requires prompt recognition and management; 
joint fluid drainage and antimicrobial therapy are the corner-
stone strategies. ReA does not require a specific treatment in 
most cases. Antibiotics are usually not used in the treatment of 
ReA per se but might be indicated for the treatment of the un-
derlying infection if there is evidence of an ongoing enteric or 
genitourinary infection (2,3). The treatment protocol for C. diffi-
cile infection includes discontinuation of antimicrobial agents 
and administration of oral metronidazole (for mild-to-moderate 
disease) or oral vancomycin with or without intravenous met-
ronidazole (for severe disease) (9). Nonsteroidal anti-inflam-
matory drugs can be helpful adjuncts for the management of 
joint pain and functional limitations (2). Our patient made a full 
recovery following discontinuation of cefazolin and administra-
tion of oral metronidazole and ibuprofen. 
Conclusion
This case highlights that CDIAReA should be considered in 
the differential diagnosis of children presenting with acute and 
painful arthritis that develops in the setting of antibiotic asso-
ciated diarrhea.
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